Carle Paul is Professor and Chairman of the Department of Dermatology at Paul Sabatier University in Toulouse, France. The department has inpatient and outpatient clinics, a clinical research centre (phases 1–4), and teaching facilities. A dedicated skin cancer unit at the Cancer University Institute of Toulouse was opened in 2014. It is affiliated with the university department and comprises 16 full-time dermatologists, 10 residents, and 10 part-time consultants.
Professor Paul was Lecturer in Dermatology and Director of the Clinical Pharmacology Unit at Saint Louis Hospital and Paris VII University in Paris, France, from 1994 to 1997. In the period 1998–2005, he worked in pharmaceutical research in Switzerland, while maintaining a clinical appointment at the Department of Dermatology in Mulhouse, France. During this period, Professor Paul worked on the development of dermatological drugs, mainly for psoriasis, atopic dermatitis, and fungal skin diseases. He contributed to the development of oral and topical calcineurin inhibitors for inflammatory skin diseases and allylamine antifungal agents. He was a board member of the European Academy of Dermatology and Venereology (EADV) from 2007 to 2012 and Secretary General from 2012 to 2016. Professor Paul is currently President of the EADV (2018–2020).
Professor Paul is co-inventor of 8 patents and author of more than 350 peer-reviewed publications. His areas of research interest are inflammatory skin diseases, pharmacology, and drug development.